India to Brazil: Bevacizumab Export Trade Route

The India to Brazil Bevacizumab corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $505.0K USD. The route is dominated by BIOCON BIOLOGICS INDIA LIMITED, which alone accounts for roughly 87% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $10.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 24.8%, placing it at rank #13 among India's top bevacizumab export destinations globally.

On the import side, key buyers of Indian bevacizumab in Brazil include XXOCOXXBIOXXGICXXUK XXMITXX, BIOCON BIOLOGICS UK LIMITED, TO THE ORDER OF and 23 others. XXOCOXXBIOXXGICXXUK XXMITXX is the single largest importer with 2 shipments valued at $218.7K USD.

India's bevacizumab exports to Brazil are driven primarily by a handful of large-scale manufacturers. BIOCON BIOLOGICS INDIA LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, SPECIALITY MEDICINES LIMITED, VAMA LIFECARE PRIVATE LIMITED — together account for 94% of total trade value on this route. The average shipment value of $10.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as abevmy 25 mg/ml bevacizumab and harmless pharmaceutical medicines for human use - bevacizumab injection, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, XXOCOXXBIOXXGICXXUK XXMITXX is the largest importer with 2 shipments worth $218.7K USD — representing 43% of all bevacizumab imports from India on this route. A total of 26 buyers are active on this corridor.